Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure

Hiroshi Yagi, Biju Parekkadan, Kazuhiro Suganuma, Alejandro Soto-Gutierrez, Ronald G. Tompkins, Arno W. Tilles, Martin L. Yarmush

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Cell-based technologies to support/restore organ function represent one of the most promising avenues in the treatment of acute liver failure (ALF). Recently, mesenchymal stem cells (MSCs) have been reported as a new therapeutic for inflammatory conditions. Here, we demonstrate the efficacy of MSCs, when cocultured with hepatocytes, to provide combination hepatic and antiinflammatory therapy in the setting of ALF. MSCs were shown to have multiple beneficial effects in vitro that were relevant in a therapeutic context, including (1) hepatocellular functional support, (2) secretion of molecules that inhibit hepatocyte apoptosis, and (3) modulation of an acute phase response by hepatocytes cultured in ALF-induced serum. In addition, we show that the MSC secretome is dynamically changed in response to serum exposure from ALF rats. We then conducted a therapeutic trial of liver assist devices (LADs). LADs containing cocultures of MSCs and hepatocytes provided a greater survival benefit compared to other coculture and monocellular control LADs. Treatment with MSC-hepatocyte devices was associated with specific improvements in hepatic functional and histological parameters as well as decreasing inflammatory serum cytokine levels, validating a combined therapeutic effect. Moreover, MSC coculture reduced the overall cell mass of the device by an order of magnitude. These findings demonstrate the importance of nonparenchymal cells in the cellular composition of LADs, and strongly support the integration of MSCs into hepatocyte-coculture-based LADs as a potential destination therapy for ALF.

Original languageEnglish
Pages (from-to)3377-3388
Number of pages12
JournalTissue Engineering - Part A
Volume15
Issue number11
DOIs
Publication statusPublished - 2009 Nov 1

ASJC Scopus subject areas

  • Bioengineering
  • Biochemistry
  • Biomaterials
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure'. Together they form a unique fingerprint.

  • Cite this

    Yagi, H., Parekkadan, B., Suganuma, K., Soto-Gutierrez, A., Tompkins, R. G., Tilles, A. W., & Yarmush, M. L. (2009). Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Engineering - Part A, 15(11), 3377-3388. https://doi.org/10.1089/ten.tea.2008.0681